Mesoblast MESO
NASDAQ MESO
$17.28 +0.14 (+0.82%)
As of: Sep 4, 2026 · 3:17 PM EDT

Mesoblast (MESO) Shares Outstanding (2014 - 2026)

Mesoblast (MESO) posted Shares Outstanding (Entity) of $129.0 for Q4 2025, down 100.0% sequentially from $120.8 million in Q2 2025, and up 13.16% YoY from $114.0 in Q4 2024.

Analysis

Mesoblast (MESO) Shares Outstanding (2014 - 2026) Analysis & Trends

Mesoblast has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $129.0 in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 13.16% year-over-year to $129.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129.0 (up 13.16% YoY) and the FY2025 annual result came in at $120.8 million, up 121999206.06% from the prior year.
  • Shares Outstanding (Entity) slipped to $129.0 in Q4 2025 per MESO's latest filing, from $120.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $120.8 million in Q2 2025 and troughed at $60.0 in Q1 2021.
  • A 5-year average of $8.1 million and a median of $74.0 in 2022 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) slumped 32.94% in 2024, then surged 121999206.06% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $65.0 in 2021, then grew by 13.85% to $74.0 in 2022, then jumped by 129.73% to $170.0 in 2023, then plunged by 32.94% to $114.0 in 2024, then advanced by 13.16% to $129.0 in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $129.0, $120.8 million, and $114.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 61.30 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 210.89 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 445.06 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
10 Mesoblast 2.23 Bn 2.13 Bn - 129.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 129.49 Mn
Dec 31, 2025 120.78 Mn
Jun 30, 2025 120.78 Mn
Dec 31, 2024 98.67 Mn
Jun 30, 2024 98.67 Mn
Dec 31, 2023 73.90 Mn
Jun 30, 2023 73.90 Mn
Mar 31, 2023 64.89 Mn
Dec 31, 2022 64.89 Mn
Sep 30, 2022 64.89 Mn
Jun 30, 2022 64.89 Mn
Mar 31, 2022 60.51 Mn
Dec 31, 2021 60.51 Mn
Sep 30, 2021 60.51 Mn
Jun 30, 2021 60.51 Mn
Mar 31, 2021 52.88 Mn
Dec 31, 2020 52.88 Mn
Sep 30, 2020 52.88 Mn
Jun 30, 2020 52.88 Mn
Mar 31, 2020 49.44 Mn